Loading...
Nu-Med Plus, Inc.
NUMD•PNK
Healthcare
Medical - Devices
$0.05
$0.00(0.00%)
Nu-Med Plus, Inc. (NUMD) Financial Performance & Income Statement Overview
Review Nu-Med Plus, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
0.00%
Operating Income Growth
47.45%
↑ 47.45%
Net Income Growth
45.55%
↑ 45.55%
Operating Cash Flow Growth
93.32%
↑ 93.32%
Operating Margin
0.00%
Gross Margin
0.00%
Net Profit Margin
0.00%
ROE
35.32%
↑ 35.32%
ROIC
29.44%
↑ 29.44%
Nu-Med Plus, Inc. (NUMD) Income Statement & Financial Overview
Review Nu-Med Plus, Inc.'s (NUMD) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $300.00 |
| Gross Profit | $0.00 | $0.00 | $0.00 | -$300.00 |
| Gross Profit Ratio | ||||
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $9294.00 | $17417.00 | $16040.00 | $20579.00 |
| Operating Expenses | $9294.00 | $17417.00 | $16040.00 | $20579.00 |
| Total Costs & Expenses | $9294.00 | $17417.00 | $16040.00 | $20579.00 |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $1261.00 | $1260.00 | $1247.00 | $1247.00 |
| Depreciation & Amortization | $0.00 | $0.00 | $0.00 | $20579.00 |
| EBITDA | -$9294.00 | $0.00 | $0.00 | $0.00 |
| EBITDA Ratio | ||||
| Operating Income | -$9294.00 | -$17417.00 | -$16040.00 | -$20580.00 |
| Operating Income Ratio | ||||
| Other Income/Expenses (Net) | -$1261.00 | -$1260.00 | -$1247.00 | -$1247.00 |
| Income Before Tax | -$10555.00 | -$18677.00 | -$17287.00 | -$21826.00 |
| Income Before Tax Ratio | ||||
| Income Tax Expense | $0.00 | $0.00 | $0.00 | -$20579.00 |
| Net Income | -$10555.00 | -$18677.00 | -$17287.00 | -$21826.00 |
| Net Income Ratio | ||||
| EPS | -$0.00 | -$0.00 | -$0.00 | -$0.00 |
| Diluted EPS | -$0.00 | -$0.00 | -$0.00 | -$0.00 |
| Weighted Avg Shares Outstanding | $83.55M | $81.35M | $81.35M | $83.55M |
| Weighted Avg Shares Outstanding (Diluted) | $83.55M | $81.35M | $81.35M | $83.55M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan